Outcome of patients with infantile spasms

Smail Zubcevic1, Selma Tanovic, Feriha Catibusic

  • 1Department of Pediatric Neurology, Pediatric Clinic, University Clinical Centre Sarajevo, Bosnia and Herzegovina.

Medicinski Arhiv
|June 3, 2010
PubMed

Insights

Infantile spasms (IS) in children present a significant challenge, particularly in developing nations. Despite limited treatment options, outcomes in seizure control and psychomotor development were comparable to international reports.

Area of Science:

  • Pediatric Neurology
  • Developmental Pediatrics
  • Clinical Research

Background:

  • Infantile spasms (IS) are a severe form of epilepsy in infants.
  • Early diagnosis and treatment are crucial for optimal outcomes.
  • Limited resources in developing countries can impact treatment accessibility and efficacy.

Purpose of the Study:

  • To evaluate the treatment outcomes of children diagnosed with infantile spasms (IS) between 2002 and 2006.
  • To describe the clinical characteristics of IS patients at the University Clinical Center in Sarajevo.
  • To assess the long-term psychomotor development and seizure control in this cohort.

Main Methods:

  • Retrospective analysis of 19 IS patients (2002-2006).
  • Inclusion of detailed medical histories, video-EEG, neuroimaging, and laboratory studies.
  • Assessment of seizure frequency, therapeutic response, and neurodevelopmental status.

Main Results:

  • Symptomatic IS accounted for 78.9% of cases; cryptogenic IS in 21.1%.
  • Satisfactory therapeutic response (seizure-free or >50% reduction) achieved in 89.5% of patients.
  • At follow-up (mean 42.5 months), 36.8% had severe psychomotor retardation; 4 patients (21.1%) were seizure-free with normal development.

Conclusions:

  • Treatment of IS is challenging, especially in resource-limited settings like Bosnia and Herzegovina.
  • Despite treatment limitations, seizure control and psychomotor development outcomes were comparable to international data.
  • Further research into prognostic predictors and pathophysiology may lead to improved therapies for IS.
Abstract

Related Concept Videos

Tetanus01:29

Tetanus

Tetanus is a life-threatening neurological disorder characterized by persistent muscle contractions and spastic paralysis. It is caused by Clostridium tetani, a motile, Gram-positive, rod-shaped, obligate anaerobe. These bacteria produce terminal endospores, giving them a distinctive “lollipop” or “tennis-racket” appearance. They thrive in anaerobic environments, such as those found in deep puncture wounds.Once introduced into the body, the spores germinate into vegetative cells. These cells...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Spasmolytic Agents: Chemical Classification01:29

Spasmolytic Agents: Chemical Classification

Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types: